Back
65· Active
Technology1h 36m ago
Loss of one copy of the DNA Ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations confers resistance to chemotherapy.
Archive Window: 7 Days Left
Baylor College of Medicine
Who
researchers at Baylor College of Medicine and collaborating institutions
What
Loss of one copy of the DNA Ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations confers resistance to chemotherapy.
When
Fri, 17 Jul 2026 02:56:00 GMT · 1h 36m ago
Where
Baylor College of Medicine ·
Why
Researchers identified a vulnerability in these cells that can be used to their advantage.
The Frontline Impact
How this affects you
This discovery reveals a new treatment strategy for aggressive breast cancers that are resistant to chemotherapy.
Story chain
1 event in this threadNo related history yet - this is the origin event.